The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A randomised phase 2 study of liposomal irinotecan in combination with 5-fluorouracil/leucovorin and oxalipalatin versus nab-paclitaxel plus gemcitabine in unresectable locally advanced or metastatic pancreatic cancer.
 
Chuntao Gao
No Relationships to Disclose
 
Xingyun Chen
No Relationships to Disclose
 
Jihui Hao
No Relationships to Disclose
 
Yanqiao Zhang
No Relationships to Disclose
 
Xiujuan Qu
No Relationships to Disclose
 
Jingdong Zhang
No Relationships to Disclose
 
Heshui Wu
No Relationships to Disclose
 
Meili Sun
No Relationships to Disclose
 
Yong Zha
No Relationships to Disclose
 
Junbin Wang
No Relationships to Disclose
 
Yusheng Wang
No Relationships to Disclose
 
Zhihua Li
No Relationships to Disclose
 
Ying Cheng
No Relationships to Disclose
 
Yanping Liu
No Relationships to Disclose
 
Niu Miao
No Relationships to Disclose
 
Yijiao Xie
No Relationships to Disclose